OUR PORTFOLIO

Our portfolio includes grants and mission-related investments supporting Alzheimer’s drugs in development, biomarkers, prevention programs, and other projects designed to build the capacity of the field. You can explore the programs we have supported using the filter and “Search Database” options in the sidebar.

All Filters

Clear
Clear
Clear
Clear
Clear
Clear
Clear
Investigator: Bradford Navia

1 Projects | 1 Researchers | $5,000,000 Invested

2023

Therini Bio

Bradford Navia, MD, PhD

Translation Studies and Clinical Development of THN391, a Novel Anti-Fibrin Antibody for the Treatment of Dementia

  • Funding Amount: $5,000,000
  • Organization Type: Biotechnology/For Profit
  • Program: Clinical
  • Target: Neuroinflammation
  • Status: Active